High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma
- PMID: 19848064
- PMCID: PMC3064443
- DOI: 10.1016/s1479-666x(09)80008-5
High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma
Abstract
High mobility group A1 (HMGA1) proteins are architectural transcriptional factors that are over-expressed in a wide range of human malignancies. Recently published evidence suggests HMGA1 is a promising candidate biomarker and therapeutic target in pancreatic cancer. This review summarises data implicating HMGA1 as an important mediator of progression in human cancer and in pancreatic cancer.
Figures


Similar articles
-
High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.Cancer. 2008 Jul 15;113(2):302-14. doi: 10.1002/cncr.23560. Cancer. 2008. PMID: 18473350 Free PMC article.
-
The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.Pancreatology. 2012 Jul-Aug;12(4):372-9. doi: 10.1016/j.pan.2012.05.005. Epub 2012 May 29. Pancreatology. 2012. PMID: 22898640 Free PMC article.
-
High mobility group A1 and cancer: potential biomarker and therapeutic target.Histol Histopathol. 2012 May;27(5):567-79. doi: 10.14670/HH-27.567. Histol Histopathol. 2012. PMID: 22419021 Review.
-
HMGA1 in cancer: Cancer classification by location.J Cell Mol Med. 2019 Apr;23(4):2293-2302. doi: 10.1111/jcmm.14082. Epub 2019 Jan 7. J Cell Mol Med. 2019. PMID: 30614613 Free PMC article. Review.
-
HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma.Cancer Res. 2006 Dec 15;66(24):11613-22. doi: 10.1158/0008-5472.CAN-06-1460. Cancer Res. 2006. PMID: 17178855
Cited by
-
HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation.J Clin Invest. 2023 Mar 15;133(6):e151601. doi: 10.1172/JCI151601. J Clin Invest. 2023. PMID: 36919699 Free PMC article.
-
Adenovirus-Mediated Delivery of Decoy Hyper Binding Sites Targeting Oncogenic HMGA1 Reduces Pancreatic and Liver Cancer Cell Viability.Mol Ther Oncolytics. 2018 Jan 31;8:52-61. doi: 10.1016/j.omto.2018.01.002. eCollection 2018 Mar 30. Mol Ther Oncolytics. 2018. PMID: 29511732 Free PMC article.
-
HMGA1 expression levels are elevated in pancreatic intraepithelial neoplasia cells in the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer.Br J Cancer. 2017 Aug 22;117(5):639-647. doi: 10.1038/bjc.2017.216. Epub 2017 Jul 11. Br J Cancer. 2017. PMID: 28697176 Free PMC article.
-
Mandatory role of HMGA1 in human airway epithelial normal differentiation and post-injury regeneration.Oncotarget. 2018 Feb 16;9(18):14324-14337. doi: 10.18632/oncotarget.24511. eCollection 2018 Mar 6. Oncotarget. 2018. PMID: 29581847 Free PMC article.
-
Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer.Tumour Biol. 2015 Feb;36(2):1213-9. doi: 10.1007/s13277-014-2749-4. Epub 2014 Oct 25. Tumour Biol. 2015. PMID: 25344216
References
-
- CancerStats. http//:info.cancerresearchuk.org/cancerstats.
-
- Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56(2):106–30. - PubMed
-
- CancerStats. http//:info.cancerresearchuk.org/cancerstats.
-
- American Cancer Society. Cancer facts and figures 2007. 2007. http://www.cancer.org/docroot/CRI/CRI_2_1x.asp?dt=34.
-
- Bramhall SR, Allum WH, Jones AG, et al. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg. 1995;82(1):111–15. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical